X. Yiakoumis

发表

Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group

M. Angelopoulou, F. Kontopidou, G. Pangalis, 2014, Leukemia & lymphoma.

Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma

G. Rassidakis, P. Korkolopoulou, M. Angelopoulou, 2012, Leukemia & lymphoma.

Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2011, Leukemia & lymphoma.

Primary adult-onset macrophage activation syndrome with multisystemic tissue phagocytosis

K. Konstantopoulos, G. Pangalis, G. Vaiopoulos, 2007 .

Is There a Role for Positron Emission Tomography (Pet/Ct) in the Initial Staging of Hodgkin Lymphoma(hl) ?

M. Angelopoulou, G. Pangalis, M. Siakantaris, 2012 .

Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2013, The oncologist.

Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukaemia: case report and literature review

G. Pangalis, G. Petrikkos, O. Nicolatou‐Galitis, 2015 .

Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor

G. Pangalis, S. Sachanas, X. Yiakoumis, 2012, Leukemia & lymphoma.

Non-gastric extra-nodal marginal zone lymphomas–a single centre experience on 76 patients

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2008, Leukemia & lymphoma.

Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome.

M. Angelopoulou, G. Pangalis, M. Kyrtsonis, 2009, Anticancer research.

New Insights into Monoclonal B-Cell Lymphocytosis

P. Korkolopoulou, M. Angelopoulou, G. Pangalis, 2014, BioMed research international.

Reversible Normolipemic Xanthelasma Palpebrarum Associated with Inflammation in Castleman's Disease

M. Tsironi, X. Yiakoumis, A. Aessopos, 2008 .

Early-stage gastric MALT lymphoma: is it a truly localized disease?

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2009, The oncologist.

Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.

B. Nathwani, G. Pangalis, K. Stefanaki, 2015, Human pathology.

Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2014, Leukemia & lymphoma.

High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article

M. Angelopoulou, E. Diamanti-Kandarakis, G. Vaiopoulos, 2015, Medicine.

Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, Tyrp-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2014, BioMed research international.

Clinical Aspects of Malt Lymphomas

P. Korkolopoulou, M. Angelopoulou, G. Pangalis, 2014, Current Hematologic Malignancy Reports.

Kikuchi’s lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome

P. Korkolopoulou, G. Pangalis, G. Levidou, 2010, Rheumatology International.

Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in “Real-Life” Outside of Clinical Trials

M. Hallek, M. Angelopoulou, G. Pangalis, 2019, AntiCancer Research.

Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?

G. Pangalis, D. Rontogianni, C. Kalpadakis, 2017, Anticancer research.

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2018, Blood.

Detection of L265P MYD‐88 mutation in a series of clonal B‐cell lymphocytosis of marginal zone origin (CBL‐MZ)

P. Korkolopoulou, M. Angelopoulou, G. Pangalis, 2017, Hematological oncology.

Malakoplakia of the Urinary Bladder in a Patient with Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: A Case Report.

G. Pangalis, D. Rontogianni, C. Kalpadakis, 2016, Anticancer research.

The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.

M. Angelopoulou, G. Pangalis, G. Tsourouflis, 2017, Anticancer research.

Indolent T-lymphoblastic proliferation: a name with specific meaning--reply.

B. Nathwani, G. Pangalis, X. Yiakoumis, 2015, Human pathology.

Eosinophilic fasciitis accompanied by serositis.

G. Vaiopoulos, G. Andreopoulos, X. Yiakoumis, 2009, The Israel Medical Association journal : IMAJ.

Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) with concurrent high grade component at diagnosis: clinico-pathologic features and treatment strategy

P. Korkolopoulou, M. Angelopoulou, G. Pangalis, 2015, Leukemia & lymphoma.

Primary effusion lymphoma in two HIV-negative patients successfully treated with pleurodesis as first-line therapy.

P. Korkolopoulou, F. Kontopidou, G. Pangalis, 2010, Anticancer research.

Long Term Response of a Patient with Lymphangiomatosis under Bevacizumab Therapy- A Case Report

G. Pangalis, S. Sachanas, M. Moschogiannis, 2020 .

Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia

P. Korkolopoulou, M. Angelopoulou, F. Kontopidou, 2014, Leukemia & lymphoma.